Mangoceuticals, Inc.
MGRX
$1.73
-$0.07-3.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.18M | -8.71M | -9.33M | -9.13M | -9.02M |
| Total Depreciation and Amortization | 1.14M | 731.50K | 16.00K | 22.00K | 25.00K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 464.30K | 222.70K | -- |
| Total Other Non-Cash Items | 3.99M | 2.45M | 2.75M | 2.33M | 1.89M |
| Change in Net Operating Assets | -95.30K | 660.30K | 668.10K | 578.10K | 921.90K |
| Cash from Operations | -6.15M | -4.86M | -5.43M | -5.98M | -6.18M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | 65.00K | 65.00K | 65.00K | 65.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 65.00K | 65.00K | 65.00K | 65.00K | 0.00 |
| Total Debt Issued | 62.50K | 150.00K | 187.50K | 187.50K | 87.50K |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -167.50K |
| Issuance of Common Stock | 2.28M | 1.33M | 1.77M | 1.77M | 2.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 3.80M | 2.65M | 2.25M | 1.50M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.15M | 4.13M | 4.21M | 3.46M | 2.32M |
| Foreign Exchange rate Adjustments | -2.20K | -9.90K | -1.70K | -1.20K | -100.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.10K | -680.40K | -1.16M | -2.46M | -3.86M |